1. Home
  2. FTHY vs CRMD Comparison

FTHY vs CRMD Comparison

Compare FTHY & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Trust High Yield Opportunities 2027 Term Fund

FTHY

First Trust High Yield Opportunities 2027 Term Fund

HOLD

Current Price

$13.59

Market Cap

494.6M

Sector

Finance

ML Signal

HOLD

Logo CorMedix Inc.

CRMD

CorMedix Inc.

HOLD

Current Price

$8.54

Market Cap

626.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTHY
CRMD
Founded
2020
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
494.6M
626.0M
IPO Year
N/A
2009

Fundamental Metrics

Financial Performance
Metric
FTHY
CRMD
Price
$13.59
$8.54
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$14.83
AVG Volume (30 Days)
103.1K
1.2M
Earning Date
01-01-0001
05-11-2026
Dividend Yield
10.93%
N/A
EPS Growth
N/A
780.00
EPS
N/A
0.43
Revenue
N/A
$311,709,000.00
Revenue This Year
N/A
$0.30
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$20.00
Revenue Growth
N/A
617.03
52 Week Low
$13.20
$6.13
52 Week High
$14.98
$15.12

Technical Indicators

Market Signals
Indicator
FTHY
CRMD
Relative Strength Index (RSI) 55.81 53.40
Support Level $13.21 $8.09
Resistance Level $13.82 $9.01
Average True Range (ATR) 0.14 0.33
MACD 0.02 -0.04
Stochastic Oscillator 82.93 40.58

Price Performance

Historical Comparison
FTHY
CRMD

About FTHY First Trust High Yield Opportunities 2027 Term Fund

FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND is a diversified, closed-end management investment company. The investment objective of the fund is to provide current income. The fund invests a majority of its managed assets in high-yield debt securities of any maturity that are rated below investment grade at the time of purchase or unrated securities. Its investment portfolio comprises corporate bonds and notes, senior floating-rate loan interests, foreign corporate bonds and notes, money market funds, and other instruments across various industries.

About CRMD CorMedix Inc.

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Share on Social Networks: